EMA Authorised: Leflunomide medac (leflunomide) — medac Gesellschaft für klinische Spezialpräparate mbH

View source ↗

Summary

The EMA authorised Leflunomide medac (leflunomide) for treatment of rheumatoid arthritis. The marketing authorization holder is medac Gesellschaft für klinische…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide medac (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid. MAH: medac Gesellschaft für klinische Spezialpräparate mbH. Decision date: 19/12/2025